Laurie McAllister
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Laurie McAllister
Non-Executive Director / Medlab Clinical
Laurie McAllister is an experienced international senior executive with strong consumer marketing and dynamic commercial experience.
Prior to becoming chief executive and managing director of McPherson's for four years to December 2020, Mr McAllister spent over 23 years with the Coca-Cola Company where he managed new product development, M&A, innovation and the research & development function across Europe, Eurasia and the Middle East.
Mr McAllister was also the president of Nordics and chief commercial & marketing officer for Japan at the Coca-Cola Company where he also represented the company on boards in Germany, Sweden, Norway, Denmark and Finland.
Prior to becoming chief executive and managing director of McPherson's for four years to December 2020, Mr McAllister spent over 23 years with the Coca-Cola Company where he managed new product development, M&A, innovation and the research & development function across Europe, Eurasia and the Middle East.
Mr McAllister was also the president of Nordics and chief commercial & marketing officer for Japan at the Coca-Cola Company where he also represented the company on boards in Germany, Sweden, Norway, Denmark and Finland.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 34th | ClearVue Technologies | 203% | 9% |
| 556th | Opyl | 7% | 97% |
| 695th | Medlab Clinical | 0% | -35% |
| 816th | London City Equities | -6% | 7% |
| 901st | Anatara Lifesciences | -11% | -41% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 843rd |  | Medlab Clinical | $6.0m |
| 986th | | London City Equities | $1.3m |
| 987th | | Anatara Lifesciences | $1.2m |
| 989th | | Opyl | $1.2m |
| 990th | | ClearVue Technologies | $1.2m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, Medlab Clinical | 03 Nov 2020 |
| NEW ROLE: Managing Director, McPherson's | 03 Nov 2020 |
